|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8837 USD | -0.57% |
|
-3.43% | -22.48% |
| 20/07 | Iridex Augments EyeProGPO Product Offering With EndoProbe Handpieces | MT |
| 14/07 | Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation | CI |
Company Valuation: IRIDEX Corporation
Data adjusted to current consolidation scope
| Fiscal Period: January | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 101.9 | 32.94 | 45.17 | 29.45 | 20.11 | 15.47 | - | - |
| Change | - | -67.66% | 37.12% | -34.81% | -31.7% | -23.08% | - | - |
| Enterprise Value (EV) | 101.9 | 32.94 | 45.17 | 29.45 | 20.11 | 15.47 | 15.47 | 15.47 |
| Change | - | -67.66% | 37.12% | -34.81% | -31.7% | -23.08% | 0% | 0% |
| P/E | -18.9x | -4.38x | -4.71x | -3.28x | -4.5x | -17.8x | 44.4x | 12.7x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.1x | -0.2x | 0.39x | 0.1x | 0.2x | -0x | 0x |
| Capitalization / Revenue | 1.89x | 0.58x | 0.87x | - | 0.38x | 0.29x | 0.27x | 0.26x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 0.29x | 0.27x | 0.26x |
| EV / EBITDA | -0x | -0x | -0x | - | 0x | 6.3x | 4.25x | 3.39x |
| EV / EBIT | -0x | -0x | -0x | - | -0x | -58.4x | 19.3x | 8.91x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.34 | -0.47 | -0.59 | -0.54 | -0.26 | -0.05 | 0.02 | 0.07 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 53.9 | 56.97 | 51.87 | - | 52.68 | 53 | 56.77 | 60.09 |
| EBITDA 1 | -6.73 | -7.057 | -7.259 | - | 1.122 | 2.457 | 3.641 | 4.559 |
| EBIT 1 | -7.533 | -7.542 | -10.01 | - | -2.571 | -0.265 | 0.801 | 1.737 |
| Net income 1 | -5.225 | -7.547 | -9.57 | -8.91 | -4.437 | -0.795 | 0.361 | 1.383 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 6.4200 | 2.0601 | 2.7800 | 1.7700 | 1.1700 | 0.8888 | 0.8888 | 0.8888 |
| Nbr of stocks (in thousands) | 15,866 | 15,990 | 16,248 | 16,636 | 17,190 | 17,407 | - | - |
| Announcement Date | 10/03/22 | 09/03/23 | 26/03/24 | 27/03/25 | 26/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.78x | - | - | - | 1.55Cr | |
| 27.93x | 5.03x | 19.28x | 0.33% | 21TCr | |
| 32.82x | 6.02x | 19.04x | 0.75% | 14TCr | |
| 39.1x | 10.15x | 22.44x | -.--% | 13TCr | |
| 16.28x | 3.44x | 11.09x | -.--% | 6.76TCr | |
| 32.28x | 6.54x | 20.69x | -.--% | 4.78TCr | |
| 18.85x | 2.16x | 11.21x | 2.78% | 4.5TCr | |
| 26.81x | 5.34x | 18.23x | 0.74% | 3.89TCr | |
| 44.99x | 6.29x | 19.31x | -.--% | 3.64TCr | |
| 19.17x | 5.04x | 12.93x | 1.2% | 2.93TCr | |
| Average | 24.05x | 5.55x | 17.14x | 0.65% | 7.37TCr | |
| Weighted average by Cap. | 29.85x | 5.94x | 18.32x | 0.49% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRIX Stock
- Valuation IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
